Coskun, B. N. Et Al. 2019. The roles of M30 and M65 in the assessment of treatment response and prognosis in patients with non-small cell lung cancer, who receive neoadjuvant treatment.. Contemporary oncology (Poznan, Poland) , vol.23, no.4 , 208-213.

Coskun, B. N., Dizdar, O. S., Korkmaz, S., Ulukaya, E., & EVRENSEL, T., (2019). The roles of M30 and M65 in the assessment of treatment response and prognosis in patients with non-small cell lung cancer, who receive neoadjuvant treatment.. Contemporary oncology (Poznan, Poland) , vol.23, no.4, 208-213.

Coskun, BELKIS Et Al. "The roles of M30 and M65 in the assessment of treatment response and prognosis in patients with non-small cell lung cancer, who receive neoadjuvant treatment.," Contemporary oncology (Poznan, Poland) , vol.23, no.4, 208-213, 2019

Coskun, BELKIS N. Et Al. "The roles of M30 and M65 in the assessment of treatment response and prognosis in patients with non-small cell lung cancer, who receive neoadjuvant treatment.." Contemporary oncology (Poznan, Poland) , vol.23, no.4, pp.208-213, 2019

Coskun, B. N. Et Al. (2019) . "The roles of M30 and M65 in the assessment of treatment response and prognosis in patients with non-small cell lung cancer, who receive neoadjuvant treatment.." Contemporary oncology (Poznan, Poland) , vol.23, no.4, pp.208-213.

@article{article, author={BELKIS NİHAN COŞKUN Et Al. }, title={The roles of M30 and M65 in the assessment of treatment response and prognosis in patients with non-small cell lung cancer, who receive neoadjuvant treatment.}, journal={Contemporary oncology (Poznan, Poland)}, year=2019, pages={208-213} }